SHERYAR SARWAR
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- KOKOMO, IN
- NPI
- 1730426958
- Received
- $21,644 in 39 records, 2019 to 2021
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2021 | General payment | 12 | $20,532 |
| 2020 | General payment | 1 | $475 |
| 2019 | General payment | 26 | $637 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $20,995 | 2020–2021 |
| Allergan, Inc. | 6 | $173 | 2019 |
| Amarin Pharma, Inc. | 2 | $130 | 2019 |
| E.R. Squibb & Sons, L.L.C. | 1 | $97 | 2019 |
| Janssen Pharmaceuticals, Inc | 3 | $44 | 2019 |
| GlaxoSmithKline, LLC. | 3 | $38 | 2019 |
| Avanir Pharmaceuticals, Inc. | 2 | $31 | 2019 |
| PFIZER INC. | 2 | $23 | 2019 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $23 | 2019 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 | 2019 |
| Novo Nordisk Inc | 1 | $15 | 2019 |
| Lilly USA, LLC | 1 | $14 | 2019 |
| Almatica Pharma LLC | 1 | $12 | 2021 |
| AstraZeneca Pharmaceuticals LP | 1 | $12 | 2019 |
| Novartis Pharmaceuticals Corporation | 1 | $11 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 11 | $20,520 |
| Food and Beverage | 25 | $631 |
| Education | 3 | $492 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2021-12-09 | Takeda Pharmaceuticals U.S.A., Inc. | $2,080 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-11-06 | Takeda Pharmaceuticals U.S.A., Inc. | $2,080 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-10-11 | Takeda Pharmaceuticals U.S.A., Inc. | $2,080 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-09-13 | Takeda Pharmaceuticals U.S.A., Inc. | $2,080 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-08-10 | Takeda Pharmaceuticals U.S.A., Inc. | $2,080 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-07-15 | Takeda Pharmaceuticals U.S.A., Inc. | $2,080 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-06-22 | Almatica Pharma LLC | $12 | Education | In-kind items and services | GRALISE Drug, POSTHERPETIC NEURALGIA | 2021 | |
| 2021-06-10 | Takeda Pharmaceuticals U.S.A., Inc. | $2,080 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-05-11 | Takeda Pharmaceuticals U.S.A., Inc. | $2,080 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-04-12 | Takeda Pharmaceuticals U.S.A., Inc. | $2,080 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-03-30 | Takeda Pharmaceuticals U.S.A., Inc. | $900 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-03-30 | Takeda Pharmaceuticals U.S.A., Inc. | $900 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2020-12-14 | Takeda Pharmaceuticals U.S.A., Inc. | $475 | Education | Cash or cash equivalent | 2020 | ||
| 2019-11-21 | Amarin Pharma, Inc. | $124 | Food and Beverage | In-kind items and services | Vascepa Drug, Hypertriglyceridemia | 2019 | |
| 2019-10-29 | Amarin Pharma, Inc. | $5 | Education | In-kind items and services | Vascepa Drug, Hypertriglyceridemia | 2019 | |
| 2019-08-21 | E.R. Squibb & Sons, L.L.C. | $97 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2019 | |
| 2019-07-17 | Allergan, Inc. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2019 | |
| 2019-06-10 | Allergan, Inc. | $24 | Food and Beverage | In-kind items and services | BYSTOLIC Drug, CARDIOVASCULAR | 2019 | |
| 2019-06-05 | Allergan, Inc. | $6 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2019 | |
| 2019-05-30 | GlaxoSmithKline, LLC. | $14 | Food and Beverage | In-kind items and services | ANORO Drug, RESPIRATORY | 2019 | |
| 2019-05-21 | Janssen Pharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-04-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | $12 | Food and Beverage | In-kind items and services | SPIRIVA RESPIMAT Drug, RESPIRATORY | 2019 | |
| 2019-04-29 | Novartis Pharmaceuticals Corporation | $11 | Food and Beverage | In-kind items and services | ENTRESTO Drug, CARDIOVASCULAR | 2019 | |
| 2019-04-24 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | CHANTIX Drug, NEUROSCIENCE;TOBACCO DEPENDENCE | 2019 | |
| 2019-04-02 | Lilly USA, LLC | $14 | Food and Beverage | In-kind items and services | TRULICITY Drug, Diabetes | 2019 | |
| 2019-03-27 | Allergan, Inc. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2019 | |
| 2019-03-13 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19 | Food and Beverage | In-kind items and services | RELISTOR Drug, GASTROENTEROLOGY | 2019 | |
| 2019-02-27 | Allergan, Inc. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2019 | |
| 2019-02-21 | Janssen Pharmaceuticals, Inc | $12 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-02-21 | GlaxoSmithKline, LLC. | $11 | Food and Beverage | In-kind items and services | ANORO Drug, RESPIRATORY | 2019 | |
| 2019-02-14 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Tresiba Drug, Diabetes | 2019 | |
| 2019-02-13 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | CHANTIX Drug, NEUROSCIENCE;TOBACCO DEPENDENCE | 2019 | |
| 2019-02-08 | GlaxoSmithKline, LLC. | $12 | Food and Beverage | In-kind items and services | BREO Drug, RESPIRATORY | 2019 | |
| 2019-02-06 | Avanir Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, pseudobulbar affect (PBA) | 2019 | |
| 2019-01-29 | AstraZeneca Pharmaceuticals LP | $12 | Food and Beverage | In-kind items and services | FARXIGA Drug, Cardiovascular and Metabolism | 2019 | |
| 2019-01-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | $10 | Food and Beverage | In-kind items and services | JARDIANCE Drug, DIABETES | 2019 | |
| 2019-01-22 | Allergan, Inc. | $4 | Food and Beverage | In-kind items and services | VIIBRYD Drug, NEUROSCIENCE | 2019 | |
| 2019-01-21 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2019 | |
| 2019-01-02 | Avanir Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | NUEDEXTA Drug, pseudobulbar affect (PBA) | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Kokomo, IN, county Howard County, IN, state Indiana; placed by its city name.
| Measure | Place (city or town) Kokomo, IN | County Howard County, IN | State Indiana |
|---|---|---|---|
| Population B01003 | 59,122 | 83,752 | 6,851,073 |
| Population, 2020 census P1 | 59,604 | 83,658 | 6,785,528 |
| Median age B01002 | 39.4 | 40.7 | 38.1 |
| Under 18 B01001 | 23.3% | 22.8% | 23.3% |
| 65 and over B01001 | 19.2% | 19.9% | 16.8% |
| Households B11001 | 26,241 | 35,593 | 2,716,009 |
| Foreign born B05002 | 2.5% | 1.9% | 6.3% |
| Median household income B19013 | $55,360 | $64,027 | $71,957 |
| Median family income B19113 | $74,956 | $84,811 | $90,767 |
| Per capita income B19301 | $32,594 | $35,963 | $38,351 |
| Poverty rate B17001 | 17.1% | 13.4% | 12.3% |
| Unemployment rate B23025 | 6.2% | 5.8% | 4.3% |
| Civilian labor force B23025 | 26,827 | 39,175 | 3,472,016 |
| Mean commute (minutes) B08013 | 19.1 | 20.4 | 24.1 |
| Bachelor's degree or higher B15003 | 18.1% | 20.8% | 29.5% |
| Housing units B25001 | 29,814 | 39,876 | 2,976,568 |
| Owner-occupied B25003 | 63.0% | 70.6% | 70.6% |
| Renters B25003 | 37.0% | 29.4% | 29.4% |
| Median home value B25077 | $137,400 | $165,000 | $218,200 |
| Median gross rent B25064 | $939 | $937 | $1,062 |
| White, not Hispanic B03002 | 78.8% | 82.6% | 75.4% |
| Black B03002 | 9.9% | 7.3% | 9.1% |
| Hispanic or Latino B03002 | 4.3% | 4.1% | 8.6% |
| Asian B03002 | 2.0% | 1.4% | 2.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Economy now FRED unemployment 3.4% in Sep 2026 (3.7% a year earlier); per capita personal income $66,455 in 2025, up 28% in five years (+3.2% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Kokomo, IN.
Comments